Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2022-06-01
2030-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China
NCT06595342
Assessing Vulnerability and Outcomes of Intracranial Atherosclerotic Plaques
NCT07156344
Clinical Registration Trial of Intracranial Stenting for Patients With Symptomatic Intracranial Artery Stenosis(CRTICAS)
NCT01994161
The Predictive Value of Retinal Vascular Signs for Intracranial Artery Stenosis (RVS-ICAS)
NCT05270746
Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
NCT01830413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Symptomatic intracranial arterial stenosis
Routine clinical treatment
Routine clinical treatment is based on the latest international and local guidelines
Asymptomatic intracranial arterial stenosis
Routine clinical treatment
Routine clinical treatment is based on the latest international and local guidelines
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Routine clinical treatment
Routine clinical treatment is based on the latest international and local guidelines
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* stenosis of a major intracranial artery.
Exclusion Criteria
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ji Xunming,MD,PhD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Suzhou Municipal Hoapital
Suzhou, Anhui, China
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Xuanwu Hospital, Capital Medical University
Beijing, , China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhengfei Ma, MD
Role: primary
Fang Xue, MD
Role: primary
Chuanjie Wu, MD
Role: primary
Yajun Lian
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICAS-Young
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.